Prospective study of factors associated with asthma attack recurrence (ATTACK) in children from three Ecuadorian cities during COVID-19: a study protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
16 06 2022
Historique:
entrez: 16 6 2022
pubmed: 17 6 2022
medline: 22 6 2022
Statut: epublish

Résumé

Asthma is a growing health problem in children in marginalised urban settings in low-income and middle-income countries. Asthma attacks are an important cause of emergency care attendance and long-term morbidity. We designed a prospective study, the Asthma Attacks study, to identify factors associated with recurrence of asthma attacks (or exacerbations) among children and adolescents attending emergency care in three Ecuadorian cities. Prospective cohort study designed to identify risk factors associated with recurrence of asthma attacks in 450 children and adolescents aged 5-17 years attending emergency care in public hospitals in three Ecuadorian cities (Quito, Cuenca and Portoviejo). The primary outcome will be rate of asthma attack recurrence during up to 12 months of follow-up. Data are being collected at baseline and during follow-up by questionnaire: sociodemographic data, asthma history and management (baseline only); recurrence of asthma symptoms and attacks (monthly); economic costs of asthma to family; Asthma Control Test; Pediatric Asthma Quality of life Questionnaire; and Newcastle Asthma Knowledge Questionnaire (baseline only). In addition, the following are being measured at baseline and during follow-up: lung function and reversibility by spirometry before and after salbutamol; fractional exhaled nitric oxide (FeNO); and presence of IgG antibodies to SARS-CoV-2 in blood. Recruitment started in 2019 but because of severe disruption to emergency services caused by the COVID-19 pandemic, eligibility criteria were modified to include asthmatic children with uncontrolled symptoms and registered with collaborating hospitals. Data will be analysed using logistic regression and survival analyses. Ethical approval was obtained from the Hospital General Docente de Calderon (CEISH-HGDC 2019-001) and Ecuadorian Ministry of Public Health (MSP-CGDES-2021-0041-O N° 096-2021). The study results will be disseminated through presentations at conferences and to key stakeholder groups including policy-makers, postgraduate theses, peer-review publications and a study website. Participants gave informed consent to participate in the study before taking part.

Identifiants

pubmed: 35710244
pii: bmjopen-2021-056295
doi: 10.1136/bmjopen-2021-056295
pmc: PMC9207574
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e056295

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

JAMA Pediatr. 2020 Mar 1;174(3):227-228
pubmed: 31904766
World Allergy Organ J. 2010 Apr;3(4):167-74
pubmed: 23268428
J Clin Epidemiol. 1995 Dec;48(12):1503-10
pubmed: 8543964
BMC Pediatr. 2012 Sep 13;12:147
pubmed: 22974166
Eur Respir J. 2012 Jan;39(1):90-6
pubmed: 21700607
Clin Rev Allergy Immunol. 2020 Aug;59(1):78-88
pubmed: 32468411
BMJ Open. 2021 Nov 1;11(11):e052971
pubmed: 34725080
J Allergy Clin Immunol. 2004 Jan;113(1):59-65
pubmed: 14713908
Am J Respir Crit Care Med. 2020 Jul 1;202(1):83-90
pubmed: 32348692
Respir Med. 2014 Feb;108(2):271-7
pubmed: 24406243
Respir Investig. 2020 May;58(3):155-168
pubmed: 32094077
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
Am J Epidemiol. 2007 Mar 15;165(6):710-8
pubmed: 17182981
Lancet Respir Med. 2021 Jul;9(7):674-675
pubmed: 33676591
Respir Res. 2017 Nov 14;18(1):191
pubmed: 29137638
Eur Respir J. 2019 Nov 14;54(5):
pubmed: 31515399
BMC Med Res Methodol. 2013 Mar 06;13:33
pubmed: 23496923
Paediatr Respir Rev. 2019 Aug;31:52-57
pubmed: 30987798
Ann Allergy Asthma Immunol. 2020 Aug;125(2):150-155
pubmed: 32339657
Nat Genet. 2014 Jan;46(1):51-5
pubmed: 24241537
Pediatr Allergy Immunol. 2015 Aug;26(5):423-30
pubmed: 25955441
Med J Aust. 2015 May 18;202(9):492-7
pubmed: 25971575
BMJ Evid Based Med. 2020 Sep 3;:
pubmed: 32883705
Am J Trop Med Hyg. 2021 Feb 25;104(4):1513-1515
pubmed: 33630751
Thorax. 2015 Sep;70(9):898-905
pubmed: 26103996
Lancet Respir Med. 2021 May;9(5):443-445
pubmed: 33721559
N Engl J Med. 2016 May 12;374(19):1842-1852
pubmed: 27168434
Allergy. 2021 Jun;76(6):1765-1775
pubmed: 33608919
World Allergy Organ J. 2020 Apr 01;13(4):100113
pubmed: 32256940
J Allergy Clin Immunol Pract. 2020 Jul - Aug;8(7):2384-2385
pubmed: 32371047
J Allergy Clin Immunol Pract. 2020 Nov - Dec;8(10):3378-3387.e11
pubmed: 32827728
World Allergy Organ J. 2016 May 04;9:13
pubmed: 27195057
Stat Med. 2009 Jul 10;28(15):1982-98
pubmed: 19452569
Eur Respir J. 2019 Jun 27;53(6):
pubmed: 31249014
Asthma Res Pract. 2017 Jan 6;3:1
pubmed: 28078100
J Asthma. 2016 Oct;53(8):816-24
pubmed: 27115719
Am J Public Health. 2012 Dec;102(12):2308-14
pubmed: 23078500
World Allergy Organ J. 2021 Jun 05;14(6):100551
pubmed: 34141051
Allergy. 2009 Mar;64(3):478-83
pubmed: 19210355
J Asthma. 2014 Apr;51(3):260-6
pubmed: 24320709
Qual Life Res. 1996 Feb;5(1):35-46
pubmed: 8901365
Thorax. 2007 Sep;62(9):758-66
pubmed: 17504817
Pediatr Pulmonol. 2018 Sep;53(9):1179-1192
pubmed: 29870146
An Pediatr (Barc). 2009 Mar;70(3):209-17
pubmed: 19409237
J Clin Epidemiol. 1995 Dec;48(12):1495-501
pubmed: 8543963
Am J Respir Crit Care Med. 2017 Jul 15;196(2):150-158
pubmed: 28282501
J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):751-8.e1
pubmed: 26028297
J Asthma. 2020 Feb;57(2):113-122
pubmed: 30915868
Eur Respir J. 2012 Dec;40(6):1324-43
pubmed: 22743675
J Allergy Clin Immunol. 2007 Apr;119(4):817-25
pubmed: 17353040
Clin Exp Allergy. 2020 Nov;50(11):1274-1277
pubmed: 32930476
J Allergy Clin Immunol Pract. 2020 Feb;8(2):626-634
pubmed: 31541763
Curr Opin Allergy Clin Immunol. 2018 Apr;18(2):117-123
pubmed: 29406359
Lancet. 2017 Jan 14;389(10065):157-166
pubmed: 27912982
J Asthma. 2017 Sep;54(7):761-767
pubmed: 27929691
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
Salud Publica Mex. 2011;53 Suppl 2:s177-87
pubmed: 21877083
J Paediatr Child Health. 1990 Aug;26(4):200-4
pubmed: 2257180

Auteurs

Diana Morillo (D)

Escuela de Medicina, Universidad Internacional del Ecuador, Quito, Ecuador.

Santiago Mena-Bucheli (S)

Escuela de Medicina, Universidad Internacional del Ecuador, Quito, Ecuador.

Angélica Ochoa (A)

Department of Biosciences, Universidad de Cuenca, Cuenca, Ecuador.

Martha E Chico (ME)

Escuela de Medicina, Universidad Internacional del Ecuador, Quito, Ecuador.

Claudia Rodas (C)

Facultad de Medicina, Universidad de Azuay, Cuenca, Ecuador.

Augusto Maldonado (A)

School of Medicine, Universidad San Francisco de Quito, Quito, Ecuador.
Emergency Department, Hospital General Docente Calderón, Quito, Ecuador.

Karen Arteaga (K)

Emergency Department, Hospital Verdi Cevallos Balda, Portoviejo, Ecuador.

Jessica Alchundia (J)

Pediatric Pneumology, Hospital de Especialidades Portoviejo, Portoviejo, Ecuador.

Karla Solorzano (K)

Pediatric Pneumology, Hospital de Especialidades Portoviejo, Portoviejo, Ecuador.

Alejandro Rodriguez (A)

Escuela de Medicina, Universidad Internacional del Ecuador, Quito, Ecuador.

Camila Figueiredo (C)

Instituto de Ciências da Saúde, Universidade Federal da Bahia, Salvador, Bahia, Brazil.

Cristina Ardura-Garcia (C)

Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Max Bachmann (M)

Norwich Medical School, University of East Anglia, University of East Anglia, Norwich, UK.

Michael Richard Perkin (MR)

Population Health Research Institute, St George's, London, UK.

Irina Chis Ster (I)

Institute of Infection and Immunity, St. George's University of London, London, UK.
Institute of Infection and Immunity, St. George's University of London, London, UK.

Alvaro Cruz (A)

Núcleo de Excelência em Asma, Universidade Federal da Bahia, Salvador, Brazil.

Natalia Cristina Romero (NC)

School of Medicine, Universidad Internacional del Ecuador, Quito, Ecuador.
GRAAL, Grups de Recerca d'America i Africa Llatines, Cerdanyola del Valles, Barcelona, Spain.

Philip Cooper (P)

Escuela de Medicina, Universidad Internacional del Ecuador, Quito, Ecuador pcooper@sgul.ac.uk.
Institute of Infection and Immunity, St. George's University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH